Johansen Kirsten L, Delgado Cynthia, Bao Yeran, Kurella Tamura Manjula
Division of Nephrology, Department of Medicine, University of California, San Francisco, California; Nephrology Section, VA Medical Center, San Francisco, California.
Semin Dial. 2013 Nov-Dec;26(6):690-6. doi: 10.1111/sdi.12126. Epub 2013 Sep 4.
Frailty is a physiologic state of increased vulnerability to stressors that results from decreased physiologic reserves or dysregulation of multiple physiologic systems. The construct of frailty has been operationalized as a composite of poor physical function, exhaustion, low physical activity, and weight loss. Several studies have now examined the prevalence of frailty among chronic kidney disease (CKD) or end-stage renal disease (ESRD) patients and have found frailty to be more common among individuals with CKD than among those without. Furthermore, frailty is associated with adverse outcomes among incident dialysis patients, including higher risk of hospitalization and death. Recent evidence shows that frail patients are started on dialysis earlier (at a higher estimated glomerular filtration rate [eGFR]) on average than nonfrail patients, but it remains unclear whether these patients' frailty is a result of uremia or is independent of CKD. The survival disadvantage that has been associated with early initiation of dialysis in observational studies could be mediated in part through confounding on the basis of unmeasured frailty. However, available data do not suggest improvement in frailty upon initiation of dialysis; rather, the trajectory appears to be toward higher levels of dependence in activities of daily living (ADLs) after dialysis initiation. Overall, there are no data to suggest that frail patients derive any benefit from early initiation of dialysis either in the form of improved survival or functional status.
衰弱是一种生理状态,由于生理储备减少或多个生理系统失调,导致对应激源的易感性增加。衰弱的概念已被定义为身体功能差、疲惫、身体活动少和体重减轻的综合表现。现在有几项研究调查了慢性肾脏病(CKD)或终末期肾病(ESRD)患者中衰弱的患病率,发现CKD患者比非CKD患者更易出现衰弱。此外,衰弱与新接受透析治疗的患者的不良结局相关,包括更高的住院和死亡风险。最近的证据表明,与非衰弱患者相比,衰弱患者开始透析的时间平均更早(估算肾小球滤过率 [eGFR] 更高),但尚不清楚这些患者的衰弱是尿毒症的结果还是独立于CKD。在观察性研究中,与早期开始透析相关的生存劣势可能部分是由于未测量的衰弱造成的混杂因素所致。然而,现有数据并未表明开始透析后衰弱状况会有所改善;相反,透析开始后日常生活活动(ADL)的依赖程度似乎会更高。总体而言,没有数据表明衰弱患者能从早期开始透析中获得任何益处,无论是生存改善还是功能状态改善。